1.1Rigid glass ampoule
A borosilicate glass ampoule holds a single dose of solution. A flame fuses the glass neck after filling, and the fused neck and glass wall limit oxygen exchange during storage.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A borosilicate glass ampoule holds a single dose of solution. A flame fuses the glass neck after filling, and the fused neck and glass wall limit oxygen exchange during storage.
A sodium selenite premix distributes the selenium dose through a blend of microcrystalline cellulose and a disintegrant before compression. The sealed blister limits moisture uptake, and the tablet breaks apart in gastrointestinal fluid to release soluble selenite.
Sodium selenate dissociates in water into sodium ions and selenate ions, which contain selenium in the +6 oxidation state. The fill volume and the sodium selenate concentration determine the elemental selenium content of each unit.
Selenomethionine dissolves in the aqueous vehicle with selenium bound within the amino acid. Intestinal amino acid transport systems take up selenomethionine after ingestion.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An oxygen-barrier flexible pouch holds an aqueous sodium selenite premix containing dissolved oxygen. A fill line supplies the premix from a stirred tank and seals the pouch at the fill port. At the feed mill, a metering pump transfers the premix from the pouch into a liquid manifold that sprays it onto feed in a ribbon mixer.
A rigid borosilicate glass cartridge replaces the flexible container and holds an aqueous sodium selenite solution containing dissolved oxygen. A fluoropolymer-faced elastomer plunger closes the rear of the cartridge, and a crimped septum seals the outlet. A dispensing actuator advances the plunger to transfer the solution through a needle that pierces the septum.
A roll of oxygen-barrier laminate forms a strip of ten independently sealed 2 mL pouches. A positive-displacement filler draws the Se(IV) solution from a closed reservoir and dispenses 2.0 mL per pouch. A heat sealer closes each fill opening, and perforations between the transverse seals let operators detach individual pouches.
An oxygen-barrier flexible pouch containing a Se(IV) solution with dissolved oxygen connects to a dedicated inlet on an automated parenteral nutrition compounder. The compounder draws solution through disposable tubing using a peristaltic pump. Its controller stops the pump when the receiving bag gains the mass corresponding to the programmed selenium addition.
An optical dissolved oxygen probe measures the Se(IV) solution in a recirculation loop upstream of the pouch filler. A hollow-fiber membrane contactor in the loop exchanges oxygen between the liquid and a gas blend supplied by oxygen and nitrogen mass-flow controllers. A controller adjusts the blend using the measured concentration and enables filling when the reading enters the configured acceptance band.
An oxygen-sensitive fluorescent patch sits on the wetted side of a transparent oxygen-barrier laminate panel in each flexible pouch. After sealing, a reader illuminates the patch through the panel and converts its fluorescence lifetime to dissolved oxygen concentration using a temperature-compensated calibration. The line controller records the reading against the pouch identifier and diverts pouches with readings outside the configured acceptance band.
A vacuum membrane contactor removes dissolved oxygen from the selenite solution before filling, and a peelable seal separates the two chambers during storage. The seal opens during preparation, which limits the time that selenite and ascorbate remain in contact before use.
A dual-chamber container holds a dry sodium selenite and mannitol cake in one chamber and water with a low dissolved oxygen content in the other. Opening the internal seal releases the diluent onto the cake, and mixing produces the solution just before use.
A flexible laminate surrounds an aluminum foil barrier with a polypropylene liquid-contact layer and an outer polyester layer. Heat seals join the polypropylene faces around the perimeter, and a sealed port provides access to the solution.
Two flexible barrier-film panels enclose the liquid, and a weld joins the polymer port flange to the pouch wall. The pouch collapses as the solution leaves through the port, so dispensing requires no air inlet.
Sodium selenite dissolves in water to provide selenium in the +4 oxidation state. A membrane contactor equilibrates the solution with an oxygen and nitrogen mixture, and a temperature-compensated optical probe checks a dissolved oxygen target of 2 ppm before filling.
Selenous acid supplies selenium in the +4 oxidation state, and the solution pH determines the distribution between molecular selenous acid and its dissociated forms. Filtered air supplies oxygen through a membrane contactor, and an inline probe measures dissolved oxygen before transfer to the filling line.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
In an embodiment, the flexible infusion bag 201 is overwrapped within one or more overwraps 202 prior to sterilization of the oxidation susceptible drug solution in the flexible infusion bag 201. In an embodiment, the overwrap 202 is a barrier layer configured to reduce or preclude permeation of oxygen to the oxidation susceptible drug solution contained within the flexible infusion bag 201 during or after sterilization.B · US 2014/0303254 A1 · ¶ 47
Especially preferably, the oxygen containing selenium compound is selected from selenium dioxide (SeO2), sodium selenite (Na2SeO3) and mixtures thereof.A · US 2013/0207058 A1 · ¶ 28
An empty cell means only that no passage was reproduced there.
The glasses of the present disclosure are free of disturbing shades of yellow or brown, which often occur with the production of titanium oxide containing glass compositions, when no arsenic and antimony compounds are used as refining agents.A · US 2013/0207058 A1 · ¶ 4
The glasses according to the present disclosure are particularly suitable as raw material for the production of infrared (IR) light conductors, cover glasses for photo sensors, ultraviolet (UV) filter glasses or the like.A · US 2013/0207058 A1 · ¶ 5
The drug product disclosed herein relates to a stable, ready to use parenteral drug product prepared by moist heat sterilization of a drug solution comprising an active pharmaceutical ingredient in a flexible infusion bag, wherein the active pharmaceutical ingredient in the drug product is susceptible to oxidation by ambient oxygen, light, or moisture.B · US 2014/0303254 A1 · ¶ 2
While formulating acetaminophen in pharmaceuticals, it is desirable to keep the pH of the medium between about 5 to about 6 to maximize the shelf life for the product.B · US 2014/0303254 A1 · ¶ 8
patent.fyi, US 2026/0355231 A1, claim 1, first published 2026-11-19T09:44:02-05:00, https://patent.fyi/US20260355231/, SHA-256 08b2d9b7f59f7d2f1d939c24a4fbdb47eca9ee8ae4f30094adea5577634b83cd